At Frontage, we offer a comprehensive portfolio of drug candidate evaluation services including DMPK, Safety and Toxicology, and Bioanalytical related services.
Our portfolio of Product Development and CMC services spans drug discovery to the post approval phase, including lead compound quantification and analytical testing.
With Over 20 years of experience in the execution of comprehensive Phase I-IIa studies, Frontage Clinical Services has completed more than 250 studies.
Our next generation central laboratories provide a comprehensive range of laboratory testing, global logistics and project management services
Regulated preclinical developmental and reproductive toxicity (DART) studies using mammalian research models are an important step to take before initiating clinical trials. Frontage’s scientists have over 20 years of experience running DART studies with knowledge of accurately estimating test doses, showing formulation stability, and expertise in animal handling. Our labs have the extensive capacity to run many studies, helping our sponsors meet their timelines with uncompromising quality.
Performing robust exploratory tests upfront can save time and money later on in the process. This infographic outlines the top reasons for why clients are encouraged to consider a comprehensive exploratory toxicology program and how it can provide success in GLP studies.
We know that to attract the best candidates we have to provide a stimulating and challenging work environment that gives our employees the opportunity to meet their career goals. We also recognize the need to offer a competitive benefits package for our employees and their families.Learn More